ACCELERO: Ph3 PF-08634404 + Chemo vs Pembro + Chemo in Locally Advanced or Metastatic NSCLC
Phase III Clinical Trial
AN INTERVENTIONAL PHASE 3 DOUBLE-BLIND RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER - C6461001
Participating Locations